IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,888,272 | -27.7% | 129,812 | -34.6% | 0.03% | -24.4% |
| Q2 2023 | $8,144,783 | -18.2% | 198,508 | -28.8% | 0.04% | -24.1% |
| Q1 2023 | $9,962,811 | +14.4% | 278,758 | +20.9% | 0.05% | +8.0% |
| Q4 2022 | $8,708,893 | -14.0% | 230,577 | +0.7% | 0.05% | -24.2% |
| Q3 2022 | $10,131,000 | +107.3% | 229,061 | +73.6% | 0.07% | +120.0% |
| Q2 2022 | $4,886,000 | -16.1% | 131,983 | -16.0% | 0.03% | +3.4% |
| Q1 2022 | $5,822,000 | +70.0% | 157,193 | +39.7% | 0.03% | +70.6% |
| Q4 2021 | $3,424,000 | +187.2% | 112,525 | +216.7% | 0.02% | +183.3% |
| Q3 2021 | $1,192,000 | -48.6% | 35,536 | -31.1% | 0.01% | -53.8% |
| Q1 2021 | $2,319,000 | +105.6% | 51,579 | +174.0% | 0.01% | +62.5% |
| Q3 2019 | $1,128,000 | -7.2% | 18,825 | -35.4% | 0.01% | +14.3% |
| Q2 2018 | $1,215,000 | – | 29,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |